{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:14:24Z","timestamp":1793049264881,"version":"4.5.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"UCSF Department of Pathology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Several different types of non-conventional dysplasia have been recently described in inflammatory bowel disease [IBD]. Hypermucinous, goblet cell-deficient and crypt cell dysplasias have received most attention, but there is limited information regarding their clinicopathological features and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 126 cases of hypermucinous [n = 55], goblet cell-deficient [n = 26] and crypt cell [n = 45] dysplasias from 97 IBD patients were collected from seven different institutions and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 62 [64%] men and 35 [36%] women with a mean age of 49 years [range: 20\u201378]. The majority of affected patients had longstanding IBD [mean duration: 18 years]. Nineteen [20%] patients had a concurrent history of primary sclerosing cholangitis. As a group, non-conventional dysplasia was predominantly found in patients with ulcerative colitis [UC] [n = 68; 70%] and occurred in the left colon [n = 80; 63%]; however, hypermucinous dysplasia [57%] was the least frequently associated with UC compared with goblet cell-deficient [74%] and crypt cell [89%] dysplasias [p = 0.016]. Fifty [52%] patients had a history of conventional dysplasia, detected in the same colonic segment as non-conventional dysplasia at a rate of 33%. Goblet cell-deficient dysplasia [74%] was more frequently associated with conventional dysplasia than hypermucinous [43%] and crypt cell [48%] dysplasias [p = 0.044]. While hypermucinous dysplasia often had a polypoid appearance [58%], crypt cell [96%] and goblet cell-deficient [65%] dysplasias were more likely to present as flat\/invisible lesions [p &amp;lt; 0.001]. Most lesions were low-grade [87%] at diagnosis, but goblet cell-deficient dysplasia [31%] more often showed high-grade dysplasia [HGD] compared with hypermucinous [15%] and crypt cell [0%] dysplasias [p = 0.003]. Hypermucinous dysplasia usually demonstrated a tubulovillous\/villous architecture [76%], whereas goblet cell-deficient dysplasia was predominantly tubular [92%]. A flat architecture was exclusively associated with crypt cell dysplasia [100%] [p &amp;lt; 0.001]. Immunohistochemical stain results for p53 were available for 33 lesions; 14 [42%] showed strong [3+] and patchy [10\u201350%] to diffuse [&amp;gt;50%] nuclear overexpression or null staining pattern, including four [33%] of 12 hypermucinous, two [29%] of seven goblet cell-deficient and eight [57%] of 14 crypt cell dysplastic lesions [p = 0.726]. Follow-up biopsies or resections were available for 92 low-grade lesions from 71 patients; 55 [60%] lesions, including 19 [49%] of 39 hypermucinous, 10 [59%] of 17 goblet cell-deficient and 26 [72%] of 36 crypt cell dysplastic lesions [p = 0.116], were associated with subsequent detection of HGD [n = 34; 37%] or adenocarcinoma [n = 21; 23%] at the site of previous biopsy or in the same colonic segment within a mean follow-up time of 12 months [range: &amp;lt;1\u201373].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypermucinous, goblet cell-deficient and crypt cell dysplasias have distinct clinicopathological features but appear to have a similar high risk of association with advanced neoplasia [HGD or adenocarcinoma]. More than half of the lesions [66%] presented as flat\/invisible dysplasia, suggesting that IBD patients may benefit from random biopsy sampling in addition to targeted biopsies. Although not uncommonly associated with conventional dysplasia, non-conventional dysplasia may be the only dysplastic subtype identified in IBD patients. Therefore, it is important to recognize these non-conventional subtypes and recommend complete removal and\/or careful examination and follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab120","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T15:12:16Z","timestamp":1625584336000},"page":"98-108","source":"Crossref","is-referenced-by-count":58,"title":["Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat\/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-5881","authenticated-orcid":false,"given":"Won-Tak","family":"Choi","sequence":"first","affiliation":[{"name":"University of California at San Francisco, Department of Pathology, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Salomao","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Pathology, Scottsdale, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Department of Pathology, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Alpert","sequence":"additional","affiliation":[{"name":"University of Chicago, Department of Pathology, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Setia","sequence":"additional","affiliation":[{"name":"University of Chicago, Department of Pathology, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liao","sequence":"additional","affiliation":[{"name":"University of Rochester, Department of Pathology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-8268","authenticated-orcid":false,"given":"Michael G","family":"Drage","sequence":"additional","affiliation":[{"name":"University of Rochester, Department of Pathology, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Westerhoff","sequence":"additional","affiliation":[{"name":"University of Michigan, Department of Pathology, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Cheng","sequence":"additional","affiliation":[{"name":"University of Michigan, Department of Pathology, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y","family":"Lauwers","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center, Department of Pathology, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaibin Mabel","family":"Ko","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, Department of Pathology, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2022012818435416800_CIT0001","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"2022012818435416800_CIT0002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0140-6736(90)91889-I","article-title":"Increased risk of large-bowel cancer in Crohn\u2019s disease with colonic involvement","volume":"336","author":"Ekbom","year":"1990","journal-title":"Lancet"},{"key":"2022012818435416800_CIT0003","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"2022012818435416800_CIT0004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"Laine","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2022012818435416800_CIT0005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"2022012818435416800_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations","volume":"7","author":"Van Assche","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2022012818435416800_CIT0007","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"Ullman","year":"2003","journal-title":"Gastroenterology"},{"key":"2022012818435416800_CIT0008","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2017.08.031","article-title":"Association of aneuploidy and flat dysplasia with development of high-grade dysplasia or colorectal cancer in patients with inflammatory bowel disease","volume":"153","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"key":"2022012818435416800_CIT0009","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.14298","article-title":"Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia","volume":"78","author":"Lee","year":"2021","journal-title":"Histopathology"},{"key":"2022012818435416800_CIT0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ibd\/izz171","article-title":"IBD-associated dysplastic lesions show more chromosomal instability than sporadic adenomas","volume":"26","author":"Wanders","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2022012818435416800_CIT0011","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41379-019-0419-1","article-title":"Non-conventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study","volume":"33","author":"Choi","year":"2020","journal-title":"Mod Pathol"},{"key":"2022012818435416800_CIT0012","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/his.13923","article-title":"DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease","volume":"75","author":"Wen","year":"2019","journal-title":"Histopathology"},{"key":"2022012818435416800_CIT0013","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/his.14294","article-title":"Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum","volume":"78","author":"Pereira","year":"2021","journal-title":"Histopathology"},{"key":"2022012818435416800_CIT0014","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/his.13652","article-title":"DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas","volume":"73","author":"Choi","year":"2018","journal-title":"Histopathology"},{"key":"2022012818435416800_CIT0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/gut.45.5.686","article-title":"Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations","volume":"45","author":"Andersen","year":"1999","journal-title":"Gut"},{"key":"2022012818435416800_CIT0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jclinpath-2019-206247","article-title":"Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases","volume":"73","author":"Gui","year":"2020","journal-title":"J Clin Pathol"},{"key":"2022012818435416800_CIT0017","first-page":"174A","article-title":"Novel classification of dysplasia in IBD","volume":"30","author":"Harpaz","year":"2017","journal-title":"Mod Pathol"},{"key":"2022012818435416800_CIT0018","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.gie.2006.02.005","article-title":"ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease","volume":"63","author":"Leighton","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"2022012818435416800_CIT0019","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.gie.2017.09.030","article-title":"Endoscopy in inflammatory bowel disease: advances in dysplasia detection and management","volume":"86","author":"Kaltenbach","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"2022012818435416800_CIT0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer","volume":"151","author":"Watanabe","year":"2016","journal-title":"Gastroenterology"},{"key":"2022012818435416800_CIT0021","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0016-5107(04)01710-9","article-title":"Most dysplasia in ulcerative colitis is visible at colonoscopy","volume":"60","author":"Rutter","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"2022012818435416800_CIT0022","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.gie.2006.09.025","article-title":"Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?","volume":"65","author":"Rubin","year":"2007","journal-title":"Gastrointest Endosc"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab120\/39559283\/jjab120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/1\/98\/42324036\/jjab120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/1\/98\/42324036\/jjab120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T13:45:29Z","timestamp":1643377529000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/1\/98\/6316756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2022,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab120","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,7,7]]}}}